News & Announcements

Vaccines likely induce strong, persistent immunity to COVID-19

This episode of ‘Show Me the Science’ details how School of Medicine scientists began working with the virus, ramping up research efforts while the rest of the world was shutting down

It’s hard to imagine we’ve already left 2020 behind us. In the new year, we at MSD are committed to continually evolving our technology platform to enable researchers such as yourself to solve complex biological questions in areas such as drug discovery, basic medical research and companion diagnostics. To help accommodate funding in the new […]

Orders must be in by Friday, December 18th to ensure delivery before January 12th, 2021 .  Save 50% on our fg/mL level ultra-sensitive assay platform (link to S-PLEX )  Save between 20% and 30% on select R-PLEX antibody pairs and assays (link to R-PLEX )  Save between 20% and 30% on select U-PLEX kits (link to U-PLEX )  Save between 20% and 25% on […]

For more information please contact Diane Bender in the IML or Craig Lanio with Millipore Sigma.

On June 12, 2020, the IML and the Shreiber Lab participated in Wear White for a Future.  By wearing white together, we are standing for science and the search for immune-based cures. Wear White Day is critical part of June’s Cancer Immunotherapy Month awareness and education programs. #Immune2Cancer

Accurate, reliable fg/ml biomarker measurements at the bench? — No Problem!! JUST LAUNCHED!! NEW MSD S-PLEX Ultra-Sensitive Assays.  Drive your biomarker measurements down to new LOWS!! Unlike other companies – MSD won’t make you buy new instrumentation to take advantage of this groundbreaking technology and assays. S-PLEX kits can be run on our S600, SQ120, […]

A human antibody that protects mice against a wide range of lethal flu viruses could be the key to a universal vaccine and better treatments for severe flu disease, according to a new study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and […]

A new School of Medicine study indicates a way for cancer immunotherapy to spur a more robust immune response. Such knowledge could lead to the development of better cancer vaccines and more effective immunotherapy drugs.

Washington University School of Medicine in St. Louis has established a Division of Physician-Scientists to help nurture the career development of physicians who want to conduct scientific research. The new division will be headed by Wayne M. Yokoyama, MD, the Sam J. Levin and Audrey Loew Levin Professor of Arthritis Research.